N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma

NCT00885326 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: Bevacizumab
DRUG: cyclophosphamide
DRUG: zoledronic acid

Sponsor

New Approaches to Neuroblastoma Therapy Consortium

Collaborators

[object Object]